Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Rossana Poli"'
Autor:
Federica Negri, Gianluca Tomasello, Rodolfo Passalacqua, Alessandra Curti, Matteo Brighenti, Lucio Olivetti, Mario Martinotti, Wanda Liguigli, Rossana Poli, Gianvito Donati, Silvia Lazzarelli, Massimo Rovatti
Publikováno v:
Gastric Cancer. 17:711-717
We previously studied a dose-dense TCF (TCF-dd) regimen demonstrating its feasibility and an activity comparable to epirubicin-based chemotherapy and TCF q3w in terms of overall survival and time to progression (TTP). We report here the final results
Autor:
Rossana Poli, Rodolfo Passalacqua, Enrico Betri, Gianluca Tomasello, Margherita Ratti, Mario Crispino, Roberto Poli
Publikováno v:
SpringerPlus
Pituitary metastases are unusual complications of malignancies. In about only 2% of patients they origin from colorectal cancer (CRC), with breast and lung as the most common primary tumors. Nevertheless, some authors reported a recent increase of th
Autor:
Federica Negri, Rodolfo Passalacqua, Gianluca Tomasello, Rossana Poli, Margherita Ratti, Stefano Panni, Bruno Perrucci, Roberto Arnaudi, Luigi Benecchi, Wanda Liguigli, Laura Toppo, Michele Potenzoni, Matteo Brighenti, Maria Olga Giganti, Maddalena Donini, Andrea Prati, Silvia Lazzarelli
Publikováno v:
Journal of Clinical Oncology. 33:303-303
303 Background: Currently, cisplatin, gemcitabine, paclitaxel (CGP) and MVAC are the most active regimens in transitional-cell carcinoma (TCC). We tested the hypothesis that two sequential non-cross-resistant, dose-dense (DD) regimens may target diff
Autor:
Fabiana Gerevini, Massimo Rovatti, Margherita Ratti, Rodolfo Mattioli, Chiara Colombi, Laura Toppo, Silvia Lazzarelli, Federica Negri, Lucio Olivetti, Rossana Poli, Wanda Liguigli, Mario Martinotti, Gianluca Tomasello, Rodolfo Passalacqua, Alessandra Curti
Publikováno v:
Journal of Clinical Oncology. 33:146-146
146 Background: Gastric cancer is a highly aggressive disease. No established standard first-line regimens are currently available. Aim of this study is to evaluate efficacy of dose-dense chemotherapy with DCF combined with P in patients (pts) with l
Autor:
Rodolfo Passalacqua, Rossana Poli, Margherita Ratti, Wanda Liguigli, Laura Toppo, Bianca Maria Donida, Gianluca Tomasello, Silvia Lazzarelli
Publikováno v:
Journal of Clinical Oncology. 32:e15006-e15006
e15006 Background: At diagnosis BM occur in approximately 10-15% of AGC pts and their prognosis is poor (Park 2011; Silvestris 2013). Aim of this study is to identify the main features of pts with AGC and BM at diagnosis together with their response
Autor:
Luigi Benecchi, Bruno Perrucci, Mariangela Maltese, Laura Toppo, Wanda Liguigli, Federica Negri, Margherita Ratti, Rossana Poli, Michele Potenzoni, Gianluca Tomasello, Rodolfo Passalacqua, Daniel Martens, Maddalena Donini, Andrea Prati, Matteo Brighenti, Carlo Del Boca, Stefano Panni
Publikováno v:
Journal of Clinical Oncology. 31:e15502-e15502
e15502 Background: mUC is a chemotherapy sensitive tumor. Currently, CGP and MVAC are the most active regimens in this setting. According to Norton and Simon hypothesis, the administration of two sequential non cross-resistant, dose-dense chemotherap
Autor:
Rossana Poli, Stefano Panni, Chiara Colombi, Roberto Delfrate, Alessandra Curti, Bruno Perrucci, Gianluca Tomasello, Wanda Liguigli, Mariangela Maltese, Federica Negri, Maddalena Donini, Rodolfo Passalacqua, Silvia Lazzarelli, Matteo Brighenti, Marco Vismarra, Margherita Ratti, Laura Toppo
Publikováno v:
Journal of Clinical Oncology. 31:4112-4112
4112 Background: TCF is a standard first line option for GEC. The Norton-Simon hypothesis suggests that chemotherapy efficacy can be enhanced by decreasing intervals between cycles. We previously reported on the high activity of TCF-dd in GEC (Tomase
Autor:
Federica Negri, Stefano Panni, Bruno Perrucci, Gianluca Tomasello, Mariangela Maltese, Laura Toppo, Margherita Ratti, Rossana Poli, Wanda Liguigli, Maddalena Donini, Matteo Brighenti, Alessandra Curti, Chiara Colombi, Massimo Rovatti, Rodolfo Passalacqua, Silvia Lazzarelli, Mario Martinotti
Publikováno v:
Journal of Clinical Oncology. 31:e15086-e15086
e15086 Background: Gastric cancer is more common in elderly pts with its highest incidence around the seventh decade of life. Most oncologists are reluctant to treat this population with the most active polichemotherapy combinations because of safety
Autor:
Rodolfo Passalacqua, Margherita Ratti, Rossana Poli, Wanda Liguigli, Laura Toppo, Federica Negri, Silvia Lazzarelli, Gianluca Tomasello, Matteo Brighenti, F. Gerevini
Publikováno v:
Annals of Oncology. 23:ix232
Background GC is more common in elderly patients (pts). Most oncologists are reluctant to treat this pts population with the most active poli-chemotherapy combinations because of safety concerns. Subgroup analysis of elderly pts enrolled in European
Autor:
Rodolfo Passalacqua, Wanda Liguigli, Stefano Panni, Rossana Poli, Mariangela Maltese, Matteo Brighenti, Alessandra Curti, Maddalena Donini, Silvia Lazzarelli, Gianluca Tomasello, Margherita Ratti, Laura Toppo, Federica Negri
Publikováno v:
Journal of Clinical Oncology. 30:4097-4097
4097 Background: MGC is a chemosensitive tumour. According to the Norton-Simon hypothesis, a reduction of tumor burden could best be achieved by shortening the interval between the cycles, and the resistance might be overcome by switching from initia